Recombinant rat MOG (1-125)

Overview

Recombinant rat Myelin Oligodendrocyte Glycoprotein (MOG) (1-125) is a key protein that plays a significant role in the central nervous system (CNS). This glycoprotein, a member of the immunoglobulin superfamily, is expressed exclusively in the CNS and is known for its vital contribution as an autoantigen in multiple sclerosis (MS). In particular, it has been implicated in the pathology of MS and experimental autoimmune encephalomyelitis (EAE) across various models, including rodents and monkeys.

At AnaSpec, we offer this recombinant protein that encapsulates the first 125 amino acids of rat MOG, providing researchers with a valuable tool to explore MS-related pathways and therapeutic targets. The sequence (Accession #CAE84068) corresponds to the extracellular domain of rat MOG, ensuring high-quality research outcomes.

Key Features

• Purified recombinant protein suitable for research and diagnostic applications
• High purity and quality, ensuring reliable results in experiments
• Facilitates the study of MS and related neurological disorders
• Available in various formats for optimal experimental design
• Compatible with multiple assay types, enhancing versatility

Specifications

FAQ

What is Recombinant MOG used for?

Recombinant rat MOG is primarily used in research focused on multiple sclerosis and other neuroinflammatory conditions, as it serves as a significant autoantigen.

How is the purity of Recombinant MOG assessed?

Purity assessments are performed using techniques such as SDS-PAGE and mass spectrometry, ensuring that our recombinant proteins meet high-quality standards.

Is Recombinant MOG available for other species?

Yes, we also offer recombinant versions of MOG from other species, including mouse and human.

Enhance your research capabilities with our recombinant rat MOG (1-125). Purchase now for insightful experiments and discoveries.

Related Products

• EndoClear™ Plus human recombinant a-Synuclein protein